GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)

Clinical trial NCT07058298 · RECRUITING

Trial details

NCT number: NCT07058298
Sponsor: Daishi Tian
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Generalized Myasthenia Gravis (gMG)

Start date: 2025-07-15
Primary completion: 2027-02-13
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.